Heparin-induced thrombocytopenia is a prothrombotic adverse drug effect induced by
platelet-activating antibodies against multimolecular complexes of platelet factor 4 and …

Heparin was discovered 90 years ago, 1 and within 2 decades it was being widely used as
an anticoagulant. 2 The numerous advantages of heparin lend to its broad use including its …

Management of heparin-induced thrombocytopenia : Current Opinion in Hematology
Management of heparin-induced thrombocytopenia : Current Opinion in Hematology Log in or …

This thoroughly updated fifth edition from international experts Warkentin and Greinacher is
the gold standard for accurate diagnosis and management of heparin-induced …

Heparin-induced thrombocytopenia (HIT) is an immune-mediated disorder caused by the
development of antibodies to platelet factor 4 (PF4) and heparin. The thrombocytopenia is …

Background The current gold-standard for diagnosing heparin-induced thrombocytopenia is
the detection of platelet-activating antibodies by means of functional assays which, since …

Heparin-induced thrombocytopenia (HIT) is a drug-mediated, prothrombotic disorder caused
by immunization against platelet factor 4 (PF4) after complex formation with heparin or other …

Heparin-induced thrombocytopenia (HIT) is a prothrombotic disorder caused by antibodies
that recognize complexes of platelet factor 4 (PF4) and heparin. HIT is frequently considered …

Two decades of research into heparin‐induced thrombocytopenia (HIT) permit a personal
historical perspective on this fascinating syndrome. Previously, the frequency of HIT was …

Heparin-associated thrombocytopenia with thrombosis (HATT) is an uncommon syndrome
that is estimated to occur in 1-5% of patients with heparin-induced thrombocytopenia. Early …